Baxfendy approved in the US as the first and only aldosterone synthase…
AstraZeneca’s Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the…
Fonte
astrazeneca.com
1articoli totali nell'archivio